Literature DB >> 29930296

PTCH1 isoform 1b is the major transcript in the development of basal cell nevus syndrome.

Robbert-Jan C A M Gielen1, Marieke G H C Reinders1,2, Hannele K Koillinen3, Aimée D C Paulussen4, Klara Mosterd1,2, Michel van Geel5,6,7.   

Abstract

Basal cell nevus syndrome (BCNS) is an autosomal dominant disorder most commonly caused by a germline mutation in the PTCH1 gene. PTCH1 is known to have different isoforms with different functional properties and expression patterns among tissues. We detected a novel, pathogenic de novo mutation in PTCH1 isoform 1b (c.114delG) in a BCNS patient. Furthermore, we elucidated the specific expression pattern of PTCH1 isoforms in normal skin, BCC and peripheral blood by studying expression of different PTCH1 isoforms. Human skin showed expression of isoforms 1b and 1d, while peripheral blood additionally showed 1a and 1e expression. BCCs showed expression of all isoforms. Here we report a patient with a novel, isoform 1b specific mutation in PTCH1 and thereby distinguish PTCH1 isoform 1b as the major transcript in the development of BCNS.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29930296     DOI: 10.1038/s10038-018-0485-0

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  13 in total

1.  Alternative first exons of PTCH1 are differentially regulated in vivo and may confer different functions to the PTCH1 protein.

Authors:  Priit Kogerman; Darren Krause; Fahimeh Rahnama; Lembi Kogerman; Anne Birgitte Undén; Peter G Zaphiropoulos; Rune Toftgård
Journal:  Oncogene       Date:  2002-09-05       Impact factor: 9.867

2.  Consensus statement from the first international colloquium on basal cell nevus syndrome (BCNS).

Authors:  Alanna F Bree; Maulik R Shah
Journal:  Am J Med Genet A       Date:  2011-08-10       Impact factor: 2.802

3.  Selective haploinsufficiency of longer isoforms of PTCH1 protein can cause nevoid basal cell carcinoma syndrome.

Authors:  Maiko Suzuki; Hiromi Hatsuse; Kazuaki Nagao; Yoshinaga Takayama; Kohzoh Kameyama; Yuji Kabasawa; Ken Omura; Masayuki Yoshida; Katsunori Fujii; Toshiyuki Miyashita
Journal:  J Hum Genet       Date:  2012-05-10       Impact factor: 3.172

4.  Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome.

Authors:  H Hahn; L Wojnowski; A M Zimmer; J Hall; G Miller; A Zimmer
Journal:  Nat Med       Date:  1998-05       Impact factor: 53.440

5.  Identification and characterization of multiple isoforms of a murine and human tumor suppressor, patched, having distinct first exons.

Authors:  Kazuaki Nagao; Masashi Toyoda; Kaori Takeuchi-Inoue; Katsunori Fujii; Masao Yamada; Toshiyuki Miyashita
Journal:  Genomics       Date:  2005-04       Impact factor: 5.736

Review 6.  Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome.

Authors:  V E Kimonis; A M Goldstein; B Pastakia; M L Yang; R Kase; J J DiGiovanna; A E Bale; S J Bale
Journal:  Am J Med Genet       Date:  1997-03-31

7.  Altered neural cell fates and medulloblastoma in mouse patched mutants.

Authors:  L V Goodrich; L Milenković; K M Higgins; M P Scott
Journal:  Science       Date:  1997-08-22       Impact factor: 47.728

8.  Distinct roles of first exon variants of the tumor-suppressor Patched1 in Hedgehog signaling.

Authors:  T Shimokawa; J Svärd; K Heby-Henricson; S Teglund; R Toftgård; P G Zaphiropoulos
Journal:  Oncogene       Date:  2007-02-19       Impact factor: 9.867

9.  Expression of the PTCH1 tumor suppressor gene is regulated by alternative promoters and a single functional Gli-binding site.

Authors:  Marie Agren; Priit Kogerman; Marika I Kleman; Martina Wessling; Rune Toftgård
Journal:  Gene       Date:  2004-04-14       Impact factor: 3.688

10.  Targeted resequencing identifies PTCH1 as a major contributor to ocular developmental anomalies and extends the SOX2 regulatory network.

Authors:  Nicolas Chassaing; Erica E Davis; Kelly L McKnight; Adrienne R Niederriter; Alexandre Causse; Véronique David; Annaïck Desmaison; Sophie Lamarre; Catherine Vincent-Delorme; Laurent Pasquier; Christine Coubes; Didier Lacombe; Massimiliano Rossi; Jean-Louis Dufier; Helene Dollfus; Josseline Kaplan; Nicholas Katsanis; Heather C Etchevers; Stanislas Faguer; Patrick Calvas
Journal:  Genome Res       Date:  2016-02-18       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.